Amarin Corp Plc (AMRN)

[Greymatter1]

Would it make sense for Amrn to change the name of V for any rx written for Marine usage vs any script written for reduce it usage? For example if Vascepa were called Trigcepa for use in triglycerides reduction, and retained the name Vascepa for cardio risk reduction, then the doctor, the pharmacist, the insurance cos, and Amrn would know that Gv could be substituted for Trigcepa but not for Vascepa. Since the generics do not or can not promote the drug for themselves then they could not be considered a substitute for the reduce it indication. Is this feasible?